Groww Logo
Home>Stocks>Glenmark Pharma

Glenmark Pharmaceuticals

Pharmaceuticals
476.35
-9.70 (2.00%) 1D
NSE
1D
1W
1M
1Y
3Y
5Y

Analyst Estimates

57%
Buy
57%
Hold
33%
Sell
10%
Aggregated by Refinitiv from 21 Analysts

Fundamentals

Market Cap₹13,441Cr
P/E Ratio14.14
P/B Ratio1.94
Industry P/E28.34
ROE14.77%
EPS(TTM)37.08
Dividend Yield0.51%
Book Value306.95
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly
See Details

About Glenmark Pharma

Glenmark Pharmaceuticals Limited is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW). It has appr
Parent OrganisationGlenmark Pharmaceuticals Limited
Founded1977
Managing DirectorMr. Glenn Saldanha
NSE SymbolGLENMARK

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
    NA
    (0.00%)
    67.10
    Cipla
      NA
      (0.00%)
      31.14
      Dr Reddy's Laboratories
        NA
        (0.00%)
        38.13
        Gland Pharma
          NA
          (0.00%)
          53.65
          Torrent Pharmaceuticals
            NA
            (0.00%)
            42.73
            Alkem Laboratories
              NA
              (0.00%)
              26.06
              Lupin
                NA
                (0.00%)
                34.28
                Cadila Healthcare
                  NA
                  (0.00%)
                  19.38
                  Aurobindo Pharma
                    NA
                    (0.00%)
                    6.69
                    Abbott India
                      NA
                      (0.00%)
                      49.90

                      FAQs on Glenmark Pharma

                      How to Buy Glenmark Pharma Share?

                      You can easily buy Glenmark Pharma shares in Groww by creating a demat account and getting the KYC documents verified online.

                      What is the Share Price of Glenmark Pharma?

                      The share price of any stocks is volatile and keeps changing throughout the day owing to different factors. Glenmark Pharma share price is ₹486.05 as of 27 Jan ‘22.

                      What is the Market Cap of Glenmark Pharma

                      Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Glenmark Pharma is ₹13,441 Cr as of 27 Jan ‘22.

                      What is the PE and PB ratio of Glenmark Pharma

                      The PE and PB ratios of Glenmark Pharma is 14.14 and 1.94 as of 27 Jan ‘22

                      What is the 52 Week High and Low of Glenmark Pharma

                      The 52-week high/low is the highest and lowest price at which a Glenmark Pharma stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Glenmark Pharma is ₹690.95 and ₹442.05 as of 27 Jan ‘22
                      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
                      MOST POPULAR ON GROWWVERSION - 2.1.6
                      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
                      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI
                      ABOUT GROWW